dc.contributor.author | Gallo, R.C. | |
dc.contributor.author | Willems, L. | |
dc.contributor.author | Hasegawa, H. | |
dc.contributor.author | Accolla, R. | |
dc.contributor.author | Bangham, C. | |
dc.contributor.author | Bazarbachi, A. | |
dc.contributor.author | Bertazzoni, U. | |
dc.contributor.author | De Freitas Carneiro-Proietti, A.B. | |
dc.contributor.author | Cheng, H. | |
dc.contributor.author | Chieco-Bianchi, L. | |
dc.contributor.author | Ciminale, V. | |
dc.contributor.author | Gessain, A. | |
dc.contributor.author | Gotuzzo Herencia, José Eduardo | |
dc.contributor.author | Hall, W. | |
dc.contributor.author | Harford, J. | |
dc.contributor.author | Hermine, O. | |
dc.contributor.author | Jacobson, S. | |
dc.contributor.author | Macchi, B. | |
dc.contributor.author | Macpherson, C. | |
dc.contributor.author | Mahieux, R. | |
dc.contributor.author | Matsuoka, M. | |
dc.contributor.author | McSweegan, E. | |
dc.contributor.author | Murphy, E.L. | |
dc.contributor.author | Péloponèse, J.-M. | |
dc.contributor.author | Reis, J. | |
dc.contributor.author | Simon, V. | |
dc.contributor.author | Tagaya, Y. | |
dc.contributor.author | Taylor, G.P. | |
dc.contributor.author | Watanabe, T. | |
dc.contributor.author | Yamano, Y. | |
dc.date.accessioned | 2019-04-25T15:46:36Z | |
dc.date.available | 2019-04-25T15:46:36Z | |
dc.date.issued | 2016 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12866/6534 | |
dc.description.abstract | Human T-cell leukemia virus-1 (HTLV-1) is the first pathogenic human retrovirus discovered in 1980. HTLV-1 causes 2 devastating diseases: adult T-cell leukemia/lymphoma (ATL) and a neurological disorder, HTLV-1–associated myelopathy/tropical spastic paraparesis (HAM/TSP or, more briefly, HAM). ATL becomes apparent in 2% to 5% of those infected with HTLV-1; another 1% to 2% will develop HAM. There are usually 2 to 3 decades of latency after the infection before the onset of symptoms. A second HTLV (HTLV-2) isolated in 1982 has been causally linked to HAM, but not ATL... | en_US |
dc.language.iso | eng | |
dc.publisher | Elsevier | |
dc.relation.ispartofseries | Blood | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | |
dc.subject | blood transfusion | en_US |
dc.subject | breast milk | en_US |
dc.subject | HTLV-1 infection | en_US |
dc.subject | HTLV-2 infection | en_US |
dc.subject | human | en_US |
dc.subject | Human T-lymphotropic virus 1 | en_US |
dc.subject | Human T-lymphotropic virus 2 | en_US |
dc.subject | nonhuman | en_US |
dc.subject | organ donor | en_US |
dc.subject | organ transplantation | en_US |
dc.subject | priority journal | en_US |
dc.subject | Review | en_US |
dc.subject | blood | en_US |
dc.subject | donor selection | en_US |
dc.subject | female | en_US |
dc.subject | HTLV-2 infection | en_US |
dc.subject | Human T-lymphotropic virus 1 | en_US |
dc.subject | Human T-lymphotropic virus 2 | en_US |
dc.subject | male | en_US |
dc.subject | procedures | en_US |
dc.subject | tropical spastic paraparesis | en_US |
dc.subject | Donor Selection | en_US |
dc.subject | Female | en_US |
dc.subject | HTLV-II Infections | en_US |
dc.subject | Human T-lymphotropic virus 1 | en_US |
dc.subject | Human T-lymphotropic virus 2 | en_US |
dc.subject | Humans | en_US |
dc.subject | Male | en_US |
dc.subject | Paraparesis, Tropical Spastic | en_US |
dc.title | Screening transplant donors for HTLV-1 and -2 | en_US |
dc.type | info:eu-repo/semantics/article | |
dc.identifier.doi | https://doi.org/10.1182/blood-2016-09-739433 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.02.06 | |
dc.subject.ocde | https://purl.org/pe-repo/ocde/ford#3.01.03 | |
dc.relation.issn | 1528-0020 |
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |